Inhibitory effect of aspirin enteric-coated tablets on platelet aggregation. It can be used for acute myocardial infarction, secondary prevention of stroke, transient cerebral ischemia, angina pectoris, after arterial surgery, prevention of deep vein thrombosis and pulmonary embolism after major surgery, and to reduce the risk of myocardial infarction episodes in patients with cardiovascular risk. After taking aspirin enteric-coated tablets may have a variety of adverse reactions such as dyspepsia, gastrointestinal and abdominal pain, increased risk of bleeding, kidney damage, allergic reactions, dizziness. It is contraindicated in people who are allergic to the components of the product, in people with asthma due to NSAIDs, in people with active peptic ulcers, in bleeding disorders, in people with severe heart, liver and kidney failure, and in the second trimester of pregnancy. Aspirin enteric-coated tablets should not be combined with methotrexate, if you need to use, please consult a professional doctor, follow the doctor’s instructions, the rational use of drugs.